| REGISTERED NUMBER: |
| Financial Statements for the Year Ended 31 December 2024 |
| for |
| Fortress Diagnostics Ltd |
| REGISTERED NUMBER: |
| Financial Statements for the Year Ended 31 December 2024 |
| for |
| Fortress Diagnostics Ltd |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Contents of the Financial Statements |
| for the year ended 31 December 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| Fortress Diagnostics Ltd |
| Company Information |
| for the year ended 31 December 2024 |
| DIRECTORS: |
| SECRETARIES: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| Chartered Accountants |
| Registered Auditors |
| Suite 5 Ormeau House |
| 91-97 Ormeau Road |
| Belfast |
| Co. Antrim |
| BT7 1SH |
| SOLICITORS: |
| Mirtna Buildings |
| 22 Market Square |
| Antrim |
| BT41 4DT |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Balance Sheet |
| 31 December 2024 |
| 2024 | 2023 |
| Notes | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Stocks | 5 |
| Debtors | 6 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 7 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
8 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Capital redemption reserve |
| Retained earnings |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Notes to the Financial Statements |
| for the year ended 31 December 2024 |
| 1. | STATUTORY INFORMATION |
| Fortress Diagnostics Ltd is a |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Revenue |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Revenue is recognised to the extent that it is probable that the economic benefits will flow to the |
| Company and the revenue can be reliably measured. Revenue is measured as the fair value of the |
| consideration received or receivable, excluding discounts, rebates, value added tax and other sales |
| taxes. The following criteria must also be met before revenue is recognised: |
| Sale of goods |
| Revenue from the sale of goods is recognised when all of the following conditions are satisfied: |
| 1. | The Company has transferred the significant risks and rewards of ownership to the buyer; |
2. | associated with ownership nor effective control over the goods sold;The Company retains neither continuing managerial involvement to the degree usually |
| 3. | The amount of revenue can be measured reliably; |
| 4. | It is probable that the Company will receive the consideration due under the transaction; and |
| 5. | The costs incurred or to be incurred in respect of the transaction can be measured reliably. |
| Tangible fixed assets |
| Short leasehold | - |
| Long leasehold | - |
| Plant and machinery | - |
| Fixtures and fittings | - |
| Motor vehicles | - |
| Stocks |
| Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition. |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Notes to the Financial Statements - continued |
| for the year ended 31 December 2024 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Research and development |
| Expenditure on research and development is written off in the year in which it is incurred. |
| Foreign currencies |
| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| Dividends |
| Equity dividends are recognised when they become legally payable. Interim equity dividends are |
| recognised when paid. Final equity dividends are recognised when approved by the shareholders at |
| an annual general meeting. |
| Going concern |
| The directors of Fortress Diagnostics Limited have reviewed the resources available and believe that |
| the company has adequate resources to continue in operational existence for the foreseeable future. |
| Accordingly, Fortress Diagnostics Limited continues to adopt the going concern basis in preparing |
| the financial statements. |
| Government grants |
| Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to |
| expenditure on tangible fixed assets are credited to profit or loss at the same rate as the |
| depreciation on the assets to which the grant relates. The deferred element of grants is included in |
| creditors as deferred income. |
| Grants of a revenue nature are recognised in the Statement of Comprehensive Income in the same |
| period as the related expenditure. |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Notes to the Financial Statements - continued |
| for the year ended 31 December 2024 |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Short | Long | Plant and |
| leasehold | leasehold | machinery |
| £ | £ | £ |
| COST |
| At 1 January 2024 |
| Additions |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| Fixtures |
| and | Motor |
| fittings | vehicles | Totals |
| £ | £ | £ |
| COST |
| At 1 January 2024 |
| Additions |
| At 31 December 2024 |
| DEPRECIATION |
| At 1 January 2024 |
| Charge for year |
| At 31 December 2024 |
| NET BOOK VALUE |
| At 31 December 2024 |
| At 31 December 2023 |
| 5. | STOCKS |
| 2024 | 2023 |
| £ | £ |
| Raw materials |
| Work-in-progress |
| Finished goods |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Notes to the Financial Statements - continued |
| for the year ended 31 December 2024 |
| 6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade debtors |
| Amounts owed by group undertakings |
| Amounts owed by participating interests | 2,377,124 | 1,617,660 |
| VAT |
| Prepayments and accrued income |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans and overdrafts |
| Other loans |
| Hire purchase contracts |
| Trade creditors |
| Tax | ( |
) | ( |
) |
| Social security and other taxes |
| VAT | 72,545 | - |
| Other creditors |
| Directors' current accounts | 225,237 | 135,977 |
| Accruals and deferred income |
| 8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Bank loans - 1-2 years |
| Other loans - 1-2 years |
| Hire purchase contracts |
| 9. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 2024 | 2023 |
| £ | £ |
| Bank loans |
| The bank loans are secured on premises at Antrim Technology Park, Antrim, County Antrim, together |
| with a fixed and floating charge over the assets of the company and a company guarantee in favour of |
| Biorex Diagnostics Limited. The directors have also provided a joint and several guarantee in the amount |
| of £250,000, and the assignment of a life insurance policy. |
| The other loan is secured on certain assets identified in the loan agreement. |
| Fortress Diagnostics Ltd (Registered number: NI038167) |
| Notes to the Financial Statements - continued |
| for the year ended 31 December 2024 |
| 10. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |
| 11. | RELATED PARTY DISCLOSURES |
| The company has taken advantage of the exemption in FRS102 Section 33 "Related party disclosures" from disclosing transactions with related parties that are wholly owned by Fortress Group Holdings Limited. |
| The Company trades with other related parties as noted below: |
| 2024 | 2023 |
| £ | £ |
| Sales to related undertakings | 1,695,899 | 2,755,067 |
| Purchases from related undertakings | 951,000 | 1,066,220 |
| Amounts owed by related undertakings | 2,377,124 | 1,871,660 |
| Amounts owed to related undertakings | - | 156,193 |
| 12. | POST BALANCE SHEET EVENTS |
| There were no events since the balance sheet date that would require adjustment or disclosure in the |
| financial statements. |
| 13. | PARENT UNDERTAKING |
| The ultimate parent undertaking continues to be Fortress Group Holdings Limited, a company incorporated in Northern Ireland. |